The current case report describes regression of digital ischemia in Thromboangiitis obliterans patient following high-dose medical cannabis therapy (MCT). MCT therapy was instituted as a pain-mitigating treatment when the patient refused amputation due to ischemic and infected foot. Three years later the digital ischemia has resolved leaving minimal scarring. The mechanism of action might be related to the anti-tobacco use effects of MCT as well as the anti-inflammatory action of CBD.
The current case report describes the use of high-dose cannabis (Medical
Cannabis Therapy, MCT) as a therapy for severe Thromboangiitis obliterans and
results three years later. A 59-year-old heavy smoking patient was admitted due
to infected and ischemic foot. The results were considered indicative of
Burger’s disease. Intravenous antibiotic therapy was begun for 4 days, with
signs of worsening infection and progression of the erythema and edema up to
the ankle. The patient returned to gainful employment after one year (gardening
technician), his work includes a physical component requiring walking, and some
ladder climbing. Further prospective clinical series is needed prior to
performance of a formal randomized clinical trial of MCT in limb ischemia.
Author(s) Details:
Dror Robinson,
Department of Orthopedic Surgery, Hasharon Hospital, Rabin Medical Center, Petah Tikwa, Affiliated with the Sackler Medical School, Tel Aviv University, Tel Aviv, Israel.
Mustafa Yassin,
Department of Orthopedic Surgery, Hasharon Hospital, Rabin Medical Center, Petah Tikwa, Affiliated with the Sackler Medical School, Tel Aviv University, Tel Aviv, Israel.
Please see the link here: https://stm.bookpi.org/ANUMS-V7/article/view/13430
No comments:
Post a Comment